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Abstract
Background: Parkinson’s disease, the second most common neurodegenerative disease, is diagnostically defined
by motor impairments, but also includes often under-recognized impairments in cognition, mood, sleep, and the
autonomic nervous system. These problems can severely affect individuals’ quality of life. In our prior research, we
have developed indicators to measure the quality of care delivered to patients with Parkinson’s disease, and we
identified gaps in delivering evidence-based treatments for this population. Effective strategies to close these gaps
are needed to improve patient quality of life.
Methods/design: Building on prior research we developed a multi-faceted proactive implementation program called
Care Coordination for Health Promotion and Activities in Parkinson’s Disease (CHAPS). To be eligible, patients had to have
at least two visits with a primary diagnosis of idiopathic Parkinson’s disease (ICD-9 code: 332.0) at one of five Veterans
Affairs Medical Centers in the southwestern United States from 2010 to 2014. The program consists of telephone
assessments, evidence-based protocols, and tools to enhance patient self-management, care planning, and coordination
of care across providers, including an electronic database to support and track coordination of care. Our mixed-methods
study employs a randomized, controlled trial design to test whether the CHAPS intervention improves performance in 38
quality measures among an analytic sample of 346 patients. The 38 quality measures are categorized into overarching
areas of communication, education, and continuity; regulatory reporting; diagnosis; periodic assessment; medication use;
management of motor and non-motor symptoms; use of non-pharmacological approaches and therapies; palliative care;
and health maintenance. Secondary outcomes are patient health-related quality of life, self-efficacy, and perceptions of
care quality. We are also evaluating the extent of the CHAPS Program implementation and measuring program costs and
impacts on health services utilization, in order to perform a analysis of the CHAPS program from the perspective of the
Veterans Health Administration (VA). Outcomes are assessed by interviewer-administered surveys collected at baseline and
at 6, 12, and 18 months, and by medical record chart abstractions. Analyses will be intention-to-treat.
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Discussion: The CHAPS Program is poised for dissemination within the VA National Parkinson’s Disease Research,
Education, and Clinical Center Consortium if demonstrated efficacious.
Trial Registration: ClinicalTrials.gov NCT01532986; registered on January 13, 2012.
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Background
Parkinson’s disease (PD) is the second most common
neurodegenerative disease, after Alzheimer’s disease, in
the United States (US) [1]. National estimates are that
60,000 new cases each year join approximately 1,500,000
individuals and their families that are afflicted with this
disease. At onset, most are over age 65 and PD affects
approximately 1.5 % of US residents 65 years and older.
However, approximately 10–20 % of PD patients are
under age 50, making this a disease that affects younger
individuals as well [2].
Motor impairments of tremor, bradykinesia, postural
instability, and rigidity define PD. Non-motor distur-
bances in cognition, mood, sleep, and the autonomic
nervous system can also severely affect quality of life for
persons with PD. While effective treatments exist, patients
may not be receiving such care. We previously conducted
a national survey that showed that primary care providers’
knowledge about PD care was much lower than that of
general neurologists [3]. We developed quality of care
indicators after performing a systematic review of the
medical literature, then convening an expert panel to rate
the indicators using a formal consensus method [4]. We
subsequently conducted a structured medical chart review
of 401 Veterans receiving care at the Veterans Affairs
Greater Los Angeles Healthcare System to determine
whether their care met the quality indicators that were
judged as highest impact by the expert panel [5]. We de-
termined that having been seen by movement disorder
specialists was associated with higher quality of care than
having been seen by general neurologists or by non-
neurologists, particularly for treatment of advanced motor
symptoms and assessment of non-motor symptoms. From
this work, we inferred that a PD care intervention to pro-
mote best practices in PD care would require: 1) care pro-
tocols that include standardized assessment of PD motor
and non-motor manifestations and 2) ongoing assessment
and collaboration with, and referral to, subspecialists for
management of certain motor manifestations or complica-
tions, as needed.
One approach to redesigning care to meet quality
goals is the Chronic Care Model (CCM) (Fig. 1) [6–8].
The CCM identifies core system components to be
addressed in chronic care redesign. Most CCM-based
interventions have shown improvement of a care process
or outcome measure and reduction of health-care costs
as a result [7, 8]. Coordination of patient care is a key
element addressed by the CCM. Studies addressing care
coordination often show improved access to care and
decreased hospitalizations [9, 10].
Care coordination, along with other CCM elements,
was a critical component of our earlier work in dementia
care and in the work of others [10–14]. In our Alzheimer’s
Disease Coordinated Care for San Diego Seniors (ACCESS)
study, a nurse- or social worker-led intervention included
structured assessment, care protocols, collaborative care
planning, coordination with care managers at community
agencies, and proactive follow-up and tracking, utilizing a
care management software program [11]. Among the posi-
tive outcomes were substantial improvement in the quality
of care. Adherence to dementia care guidelines nearly dou-
bled. Outcomes included better patient health-related qual-
ity of life, and fewer unmet caregiving assistance needs.
Telephone or on-site home assessments were associated
with better caregiver mastery [15]. Caregiver self-efficacy
improved as well.
Improving patient and caregiver self-efficacy is an im-
portant goal in efforts to improve health care quality. The
nursing profession’s biopsychosocial environmental con-
struct ideally supports a self-efficacy focus in care coord-
ination and management. Nurses bring attention to the
strengths of individuals. This in turn helps to maximize
self-management of PD and, ultimately, improvement in
individuals’ quality of life [16]. Self-management tools
tailored to PD aim to help Veterans identify health prob-
lems and apply solutions to reach specific goals, such as
controlling symptoms and knowing how health problems
affect quality of life [7, 8]. Areas of focus include integrat-
ing medication regimens into daily life, noting symptoms
and treatment effects, and learning skills and strategies for
successfully coping with difficult emotions. These approa-
ches—the CCM Model and the self-efficacy concept—are
applicable to improving PD care and can be integrated
into care coordination programs.
This study’s primary specific aim is to test a nurse-led
intervention/program, Care Coordination for Health
Promotion and Activities in Parkinson’s Disease (CHAPS).
We hypothesize that the CHAPS Program will increase
adherence to evidence-based practice guidelines and im-
prove outcomes of health-related quality of life and
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perceptions of care quality at a cost deemed feasible from
the perspective of the Veterans Health Administration
(VA).
Methods/design
The intervention being assessed, a multi-component nurse-
led care coordination clinical program, is based on adapta-
tions of our earlier research. The overall research
design is a multi-site, single-blinded, patient-level
randomized-controlled trial of the intervention rela-
tive to usual care. Analyses include both primary and
secondary outcomes as well as cost-related measures.
Setting, population, and subjects for testing the
intervention
The setting for this study includes five medical centers
within the Veteran Integrated Service Network (VISN)
22 in the southwest United States. These medical centers
are Greater Los Angeles, Las Vegas, Loma Linda, Long
Beach, and San Diego. They are part of the Southwest
Parkinson’s Disease Research, Education, and Clinical
Centers (PADRECC), which is one of eight regional net-
works in the national VA PADRECC consortium. Insti-
tutional Review Board study approval was obtained at all
sites.
Potential subjects are identified through a list of eligible
Veterans with at least two International Classification of
Diseases, Ninth Revision (ICD-9) diagnostic codes for
PD (332.0) in administrative data through a query of the
Data Warehouse for VISN 22 from October 1, 2010
through December 31, 2014 or until full enrollment is
achieved [17].
Study inclusion criteria are: 1) Veterans with a diagno-
sis of Parkinson’s disease who 1) have had at least two
visits between October 1, 2010 up to December 31, 2014
to one of the study sites; 2) are at least 18 years of age;
and 3) demonstrate ability to provide consent for study
participation. This is determined using screening ques-
tions (SAFE VET Mini Quiz) for “ability to participate in
research” to identify if help is required in communicat-
ing with the research staff.
The exclusion criteria are: 1) Veteran is unable to par-
ticipate in a dialog over the telephone, even with the
help of his or her family or friend, 2) current enrollment
in the Deep Brain Stimulation VA cooperative study,
3) enrollment in the Care Coordination Home Telehealth
program; and 4) Veterans with PD and dementia who are
unable to provide informed consent.
Development of intervention
Building on prior experiences in the ACCESS project and
related published literature, we designed an outpatient PD
care program addressing current limitations in PD care
delivery based on the CCM (Fig. 1). In CHAPS, nurse care
managers (NCMs) conduct structured assessments via
telephone to proactively identify problems and unmet
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Fig. 1 CHAPS Adaptation of the Chronic Care Model. Abbreviations: GLA—Greater Los Angeles; VAs—Veterans Health Administration;
APDA—American Parkinson’s Disease Association; LA-CRC—Los Angeles Caregiver Resource Center; NPF—National Parkinson Foundation;
PRO—Parkinson’s Resource Organization; CHAPS—Care Coordination for Health Promotion and Activities in Parkinson’s Disease; SDMM—Siebens
Domain Management Model; SHC—Siebens Health Care
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needs (Fig. 2). These trigger protocols for delivery of
evidence-based, coordinated PD treatment guidelines in
concert with Veterans’ priorities, VA providers’ expertise,
and local community resources. NCMs make telephone
calls to Veterans, send printed materials to instruct and
support self-management, and conduct clinical huddles
with neurologists, to coordinate PD care management
proactively. This program overlays the existing care deliv-
ery structure of neurologist visit-based care. In addition,
steps are embedded in the NCM protocols to address 38
PD quality indicators (Table 1). Through these approaches
and procedures, the CHAPS Program is designed to pro-
actively enhance and expand the ongoing PADRECC spe-
cialists’ care.
Intervention staffing
The central feature of the CHAPS Program is delivery
system re-design through creation of the proactive
CHAPS nurse care manager role. This clinician leads the
execution and coordination of all the care management
activities to be carried out with Veterans. Nurses may
have different backgrounds yet are required to have out-
patient care experience. Because they are part of the
clinical VA staff, they have full access to clinical re-
sources and clinical documentation systems.
Care management components
Each participating Veteran receives an initial telephone
call from the NCM to introduce him or herself as the
CHAPS Program nurse care manager, and to schedule a
time to start the CHAPS Assessment (Fig. 2) with the
Veteran. The NCM administers the comprehensive
structured assessment via telephone and then follows up
periodically. The assessment, programmed in Microsoft
(MS) Access, is based on existing validated and stan-
dardized instruments (e.g., Patient Health Questionnaire
(PHQ)-9, World Health Organization (WHO)-5, sub-
scales of the Movement Disorder Society-United
Fig. 2 Study design and CHAPS Program intervention
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Parkinson’s Disease Revised Scale (MDS-UPDRS)) and
other questions developed by the research team as cur-
rently in use in other health care settings (Table 2).
Some of these items, like the Epworth Sleep Scale, have
been adapted to fit this patient population [18]. Based
on pilot work that identified unmet care needs by Vet-
erans, assessment algorithms (triggers) are included in
the assessment to identify 28 priority problem areas
(Table 2). They are categorized as routine or urgent. For
example, a score of 10–17 points on the Epworth Sleep
Scale would be categorized as a routine problem, but a
score 18 points or greater on this scale would be catego-
rized as an urgent problem [19].
Table 1 Outcome measures—quality indicators for Parkinson’s
disease care outcome measures
Communication, Education, and Continuity Indicators:
1. Because people with PD may develop impaired cognitive ability, a
communication deficit and/or depression, they should be provided
with: both oral and written communication throughout the course of
the disease, which should be individually tailored and reinforced as
necessary consistent communication from professionals involved
2. Families and caregivers should be given information about PD and
PD with dementia (PDD) (if applicable), standards for diagnosis and
symptom assessment, clinical and social services for which they are
eligible, and the support services available including caregiver resources
and dementia care (if applicable).
3. All Veterans with PD and their caregivers (if applicable) should be
referred to one or more Parkinson’s disease advocacy and support
organizations for information, education, and support including
caregiver resources and dementia care (if applicable). (Referral to PD
advocacy and support organizations)
4. People with PD and their caregivers should be given the opportunity
to discuss end-of-life issues with appropriate healthcare professionals.
5. People with PD should have a comprehensive care plan agreed
between the individual, their family and/or caregivers and specialist and
secondary healthcare providers.
6. All Veterans with PD should be able to identify a provider or a clinic
that they would call when in need of medical care or should know the
phone number or other mechanism by which they can reach this
source of care. (Identify source of care)
Reporting Indicators:
7. If a Veteran with PD or his or her family expresses concern about
driving safely, then the clinician should advise the patient not to drive a
motor vehicle and/or request the DMV retest the patients’ ability to
drive, and/or refer the patient to a driver’s safety course that includes
assessment of driving ability, in accordance with state laws. (Actions
regarding driving safety concerns)
8. All Veterans with PD who report excessive daytime sleepiness should
be instructed not to drive a motor vehicle. (Excessive daytime
somnolence and driving restrictions)
9. All Veterans with PD who are wheelchair bound or demented should
be assessed for evidence of abuse (physical, sexual, financial, neglect,
isolation, abandonment). (Assessment for abuse)
Diagnosing Parkinson’s Disease:
10. The diagnosis of PD should be reviewed regularly (6–12 month
intervals seen to review diagnosis) and re-considered if atypical clinical
features develop.
Assessment:
11. All Veterans with PD, on at least an annual basis, should be assessed
for the following:





Presence or absence of UI during the initial evaluation and every
2 years thereafter.
Functional status. (Assessment of functional status)
Speech and swallowing difficulties
Orthostatic hypotension
Gastro-intestinal symptoms including constipation
Table 1 Outcome measures—quality indicators for Parkinson’s
disease care outcome measures (Continued)
Psychosis, hallucinations and delirium
Erectile dysfunction
Weight (at every visit)
Occurrence of recent falls
Medication Use:
12. If a Veteran with PD is prescribed a new drug, then the prescribed
drug should have a clearly defined indication documented in the
medical record. (Documented indication for newly prescribed medication)
13. For all Veterans with PD, the outpatient medical record of every
physician should contain an up-to-date medication list. (Up-to-date
medication list)
14. If a Veteran with a new diagnosis of PD has impairment in activities
of daily living and is prescribed either levodopa or a dopamine agonist
(DA), then the tradeoffs of initiating dopamine agonists versus levodopa
should be discussed with the patient. (Dopamine agonist vs. levodopa
as initial treatment)
15. If a patient has PD and has motor fluctuations, and is prescribed
levodopa, then he or she should be educated about timing of intake of
dietary amino acids and its impact on response to levodopa. (Timing of
levodopa and dietary amino acids)
16. Clinicians should be aware of dopamine dysregulation syndrome, an
uncommon disorder in which dopaminergic medication misuse is
associated with abnormal behaviors, including hypersexuality,
pathological gambling and stereotypic motor acts. This syndrome may
be difficult to manage.
Management of Motor Symptoms and Dystonias:
17. If a Veteran is receiving therapy with a dopaminergic agent
(levodopa or a dopamine agonist), then they should be assessed for
the presence of motor complications (wearing-off, on-off fluctuations,
or dyskinesia) at least every 6 months. (Assessment of motor
complications)
18. Off-Period and Early Morning Dystonias Usual strategies for
wearing-off can be applied in cases of off-period dystonia.
Management of Non-Motor Complications of Parkinson’s Disease:
19. If a patient with PD is newly treated for depression, then degree of
response to at least two of the nine DSM-IV target symptoms for major
depression and, if he or she is taking antidepressant medications,
medication side effects should be documented at the first follow-up
visit to the same physician or to a mental health provider within
4 weeks of treatment initiation.
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Care management
The NCM schedules follow-up calls, adjusted to meet
the Veteran’s needs. The NCM follows a standardized
process documented in a hard-copy Care Coordination
Binder that is also available electronically. It includes
care plans and national and regional resources for
each of the 28 priority problems (Table 2). The care
plans are structured with suggestions in each of five
steps: 1) Assess Further, 2) Inform by Providing Materials
and Education, 3) Problem-solving and Self-Management/
Self-care, 4) Clinical Referral or Follow-Up, and 5) Re-
sources in Community and VA Social Services.
Each site identifies a CHAPS Program neurologist to
serves as a champion for the Program. NCMs communi-
cate once a month, either, in-person, by telephone, or by
encrypted email with this neurologist in a “clinical
huddle”. Together the NCM and neurologist review spe-
cific problems and clarify care coordination needs. All
care is documented in the VA’s electronic medical record
for optimal communication with all care providers
within the VA.
Self-management
NCM coaching actions support self-management by in-
cluding goal setting, and use of self-management tools
such as “My Action Plan” and provision of relevant print
and/or electronic educational material. Regularly sched-
uled NCM telephone team meetings, facilitated by a
team leader, further support the self-management com-
ponent to problem solve specific challenges.
Materials for veterans
CHAPS NCMs utilize MS Word templates for the self-
management care plan, My Action Plan. The focus of the
Table 2 Comprehensive CHAPS assessment items and priority
problem areas and associated standard care plans
CHAPS assessment Priority problems/
standard care plans
I. Medical/Surgical Issues (The Body) a
Medication Reconciliation 1 Prevention




Non-motor Complications - adapted
















(depression screening in PD)




adapted from L Chew [50]
13 Cognitive Impairment
Internet Use—www.pewinternet.org 14 Psychosis/Hallucinations
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20 Impulse Control Disorder
21 Preferences/Long term
care planning




Social Isolation—PDQ-39 (IADL) [52] 23 Falls













Table 2 Comprehensive CHAPS assessment items and priority
problem areas and associated standard care plans (Continued)
IV. Living Environment (Surroundings)
Community Agency Awareness—
Adapted from ACCESS [11]
26 Elder Abuse
27 Access to Care
Access to Care—Adapted from
MS Survey [53]





a Section headings from Siebens Domain Management Model © Hilary C Siebens
MD 2005, used with permission
MDS-UPDRS Movement Disorders Society—Unified Parkinson’s Disease Rating
Scale; ADL-UPDRS Activities of Daily Living-Unified Parkinson’s Disease Rating
Scale; WHO World Health Organization; PD Parkinson’s disease; PHQ Patient
Health Questionnaire; ACCESS Alzheimer’s Disease Coordinated Care for San
Diego Seniors; PD-HRQoL Parkinson’s disease-Health-related quality of life;
PDQ Parkinson’s Disease Questionnaire; IADL intermediate or instrumental
activities of daily living; NMSS National Multiple Sclerosis Society; MOS Medical
Outcomes Study. MS Multiple Sclerosis
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initial Action Plan is orientation to the self-management
healthcare notebook and a few priority problems that the
Veteran and NCM collaboratively decide are the most
important to work on. These Veteran-focused personal-
ized action plans are used as reminders to the Veteran
about changes in lifestyle habits and other suggestions that
ideally will take place between encounters. The initial self-
management care plans are printed and mailed to
Veterans in a 3-ringed binder that is customized for each
Veteran. A printed hard copy of the initial CHAPS
Assessment is included as well. The notebook provides
Veterans with a method for keeping their important
health information in one place, for their own reference
and/or for their family and/or friend(s) who assist the
Veteran with day-to-day activities. This approach facili-
tates communication among patients’ multiple providers.
Because many Veterans receive care outside the VA where
their electronic medical information will not be available,
a printed binder given to patients provides one option for
improving communication, and in turn care coordination,
among VA and non-VA providers. In addition, research
on learning and reading suggests differences in the use of
paper versus screen presentations [20, 21]. For example,
students showed better reading comprehension of printed
texts compared to digital texts. In addition, not all
Veterans have access to or use the Internet. Therefore,
distributing a judicious amount of print material in a self-
management tool, like a 3-ringed binder, was felt to be
essential.
Additional educational materials are mailed to the
Veteran when required to work on new problems. An
updated “My Action Plan” is mailed after the yearly re-
assessment, or more often if the nurse and Veteran de-
cide that might be beneficial. CHAPS NCMs also urge
Veterans to use My HealtheVet, an online personal
health record that also offers secure messaging with the
Veteran’s provider. As part of total care management, if
a Veteran in the intervention group states that he/she
has a family or friend caregiver during the administra-
tion of the CHAPS Assessment, the NCM sends the Vet-
eran a CHAPS Intervention Caregiver Support Packet
that contains caregiver assessment questions regarding
depression, strain, social isolation, and overall health and
caregiver resource organizations.
Hospital admission notification process
The team established a “Hospital Admission Notification”
in the VA’s computerized patient records system (CPRS),
at each site, to alert the respective CHAPS NCM when an
intervention patient is admitted to a VA hospital. This
provides NCMs the opportunity to contact families to be
proactive in hospital care, as it relates to PD, especially
regarding PD medications. This notification facilitates
post-hospital PD care delivery as well.
Outcome measures
In 2011, we convened a Task Force from four regional
VA PADRECC medical centers (Greater Los Angeles,
Las Vegas, Loma Linda, and Long Beach) and included
five local PD advocacy and service organizations.
Through a formal consensus process, the Task Force
selected 38 PD quality of care indicators as having the
most room for improvement and being of high value for
treatment and management of PD (Table 1). These indi-
cators were drawn from a larger set of 106 indicators
developed from national and international work [4, 22].
Secondary outcomes
These are listed in Table 3 and will each be measured
using standardized, established measures.
Intervention costs
(1) Start-up costs to implement the intervention, such as
computer hardware, software development, and items re-
quired for care manager training, are collected. Start-up
costs are also tracked using the Intervention Activities
Log, which staff use to record time for one-time interven-
tion activities. (2) Maintenance costs will be estimated by
the Cost Assessment Activity logs, which collect the fre-
quency and time required for on-going care management
activities and resources required.
Research design
The overall research design is a randomized controlled
trial involving a comparison between arm group receiving
the nurse-led CHAPS Program intervention and a control
arm receiving care as usual (Fig. 2). Research staff asses-
sors collecting outcome data are unaware of assignment
arm so they are not influenced by that knowledge.
Randomization
Before enrollment began, the programmer created
randomization tables that assigned subjects in a 1:1 ratio
Table 3 Secondary outcome measures to evaluate CHAPS
program
Patient health-related quality of life (Health Utilities Index) [56]
Depression (WHO-5, PHQ-9) [48, 49]
Patient Self-efficacy (General Self-efficacy Scale) [57]
Patient perceptions of care quality (Consumer Assessment of Health
Plan) [58] and Patient Assessment of Care for Chronic Conditions
(PACIC) [59]
Functional Status (Subscale of UPDRS-ADL subscale) [46]
Social support (MOS Social Support Survey) [60]
Comorbidity (Charlson Comorbitiy Index) [61]
Health services utilization (VISN-22 Data Warehouse) [35]
WHO World Health Organization; PHQ Patient Health Questionnaire;
UPDRS-ADL Unified Parkinson’s Disease Rating Scale—Activities of Daily Living;
MOS Medical Outcomes Study; VISN Veteran Integrated Service Network
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to either the intervention arm or control arm. The tables
had a block size of 4 and were stratified by site. After
the research staff assessor administers the baseline inter-
view to consented study participants, the program man-
ager uses the randomization table to assign study arm.
The program manager then notifies the nurse care man-
agers of assigned intervention patients. To minimize po-
tential bias from participants’ awareness of randomization
arm assignment, all study participants (both intervention
and control arms) receive a brief educational handout on
Parkinson’s disease that is available in the VA’s “Healthwise
for Life” handbook [23, 24]. Veterans randomized to the
control arm continue to receive care they would have re-
ceived if they had not enrolled in the study.
Blinding (masking)
Since the unit of randomization is the patient rather
than the physician or clinic, physicians will know which of
their patients are receiving the intervention due to infor-
mation and communication received from the CHAPS
NCMs. However, since NCMs foster patient participa-
tion in medical care interventions, the risk of bias that
can be caused by physician awareness of group assign-
ment is decreased. The intervention is not physician-
driven so there is less likelihood of contamination. The
advantages of patient-level randomization outweigh any
disadvantage [25].
Data collection
Data are obtained by survey interviews with patients and
by electronic medical record abstraction. Telephone sur-
veys administered by trained research assistants who are
blinded to study arm assignment are conducted at base-
line, 6-, 12-, and 18 months (Fig. 3). Study participants
receive $25 per survey as recognition for their time.
Even though medical record abstractors are not made
aware of study arm assignment, these data collectors
may become unblinded to randomization status because
of the project’s CHAPS name appears in all medical rec-
ord note titles. However, the standardized chart abstrac-
tion form will guard against bias.
Data sources for the primary outcome, adherence to
38 quality indicators, are both medical record abstraction
and telephone survey of study participants. The propor-
tion of applicable recommendations followed for each
Veteran will be computed and aggregated to the two
group levels (intervention and control arms).
Development of guideline adherence measures for
those measures not previously operationalized follows a
specific process. Each PD indicator or “care goal” is con-
verted to review criteria, which are then operationalized
through specific clinical variables and chart review ques-
tions [4]. Each observable measurement is mapped to an
action/activity performed in the intervention. For example,
if the patient is taking antihypertensive medications and
has symptomatic orthostatic hypotension, then this medi-
cation should be decreased.
Sample size and level of power
The sample size calculation is based on the primary out-
come (Adherence to PD Guidelines Measure using 38
quality indicators, see below and Table 1). Guideline adher-
ence is expressed as the mean across the study participant
group of the per-patient percentage of applicable guideline
measures for which there was adherence. An applicable
PD guideline is one for which a participant is eligible.
From the literature of chronic disease coordinated
care interventions for other conditions, reported effect
sizes used for power calculations—and thus reflecting
a perceived clinically meaningful difference—range
from 0.25 to 0.5 [11, 26, 27]. These are all in the
range of a medium effect size per Cohen [28]. Next,
the attrition rates of chronic disease coordinated care
interventions for other conditions range from 10–
20 % [29–32]. Target enrollment numbers based on
variations of effect size and retention rates of 80–
Fig. 3 Enrollment of subjects and schedule for collecting
evaluation data
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90 % are shown in Table 4 and Fig. 4. Using an alpha
of 0.05, 90 % power, and an effect size of 0.35, we
calculated an analytic sample size of 346 subjects
(173 subjects in each treatment arm). Estimating a
retention rate of 85 % corresponds exactly to a target
enrollment number of 407. We choose to enroll 400
Veterans to yield an adequate analytic sample size,
N = 346, after accounting for the expected attrition
rate. Based on the distribution of PD patients across
the five VISN 22 VA Medical Centers, we expect that
30.7 % of subjects (n ~ 123) will be enrolled from VA
Greater Los Angeles, 23.8 % from VA Loma Linda
(n ~ 95), 17.6 % from VA San Diego (n ~ 71), 15.3 %
from VA Long Beach (n ~ 61), and 12.5 % from VA
Las Vegas (n ~ 50). Enrollees are randomized in a 1:1
ratio to either receive the CHAPS intervention or
care as usual.
Analysis
All analyses will follow the intention-to-treat principle in
that participants are included in the analyses regardless
of the level of exposure to the intervention activities. In
order to accomplish this analysis in patients who drop
out of the study, we will employ a conservative imput-
ation method such as last-value-carried-forward. We will
consider a p-value less than or equal to 0.05 as statisti-
cally significant.
Primary outcome: quality of care indicators for guideline
adherence
The primary outcome is adherence to 38 evidence-based
PD quality indicators (Table 1). Guideline adherence will
be determined by medical record and interview data. Out-
comes are expressed as a percentage of applicable guide-
lines followed, as identified with quality indicators on
chart review. The adherence measure will be treated as
continuously scaled.
All multivariate analyses will be preceded by bivariate
analyses to describe relationships between key variables.
Descriptive statistics will compare the two arms on socio-
demographic and clinical characteristics (such as duration
of PD) and on study outcome measures at baseline, using
two-sample t-tests for continuous variables and χ [2] tests
for categorical variables. Baseline characteristics will be
compared between participants who complete and partici-
pants who do not complete follow-up surveys. Participants
who do not finish the final interview due to medical illness
or loss to follow-up will be excluded from the analyses but
sensitivity analyses will include these participants.
An intention-to-treat analysis on all guideline adherence
over time will be conducted using linear regression (or
logistic regression when analyzing guidelines individually)
with sampling weights using the sandwich variance esti-
mator (robust variance estimator and Huber correction)
as implemented in Stata version 11 [33, 34]. Intervention
status, indicator variables for site and baseline measures
will be included as independent variables in all models.
Other potential important covariates will be selected in
advance of data analysis to be included in the model.
Secondary outcome measures
Using the data collected at baseline, 6-, 12- and 18-
month follow-up, we will examine the difference in the
Table 4 Analytic sample sizes, across a range of effect sizes and
retention rates
Effect size Analytic sample size with 90 % power
0.3 2 × 235 = 470
0.35 2 × 173 = 346
0.4 2 × 133 = 266
Fig. 4 Enrollment sample sizes for achieving analytic sample sizes; range of effect sizes and retention rates
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change score (from baseline to 6 months, baseline to
12 months, and baseline to 18 months) of the secondary
outcome measures between two study arms (Fig. 2).
These measures will be analyzed using linear regression
with sampling weights using the sandwich variance esti-
mator (robust variance estimator and Huber correction)
[33, 34]. Intervention status, indicator variables for site
and corresponding baseline measures will be included as
independent variables in all models, and potential covar-
iates associated with each outcome measure will also be
included as independent variables including the adjust-
ment variables as noted above.
Sensitivity analyses will be performed to check the ro-
bustness of the main results or to explore other associa-
tions. These will include analyses using the last observed
outcome measure carried forward to 18 months for
those who do not reach the study end point, using only
the 6 months of data, using only 12 months of data, and
testing whether outcomes change significantly over time
within each study arm.
Process evaluation analyses
A qualitative process evaluation will be conducted to as-
sess implementation process barriers and facilitators to the
intervention through review of detailed project meeting
minutes from weekly meetings with intervention arm
NCM and the clinician neurologist champion at each site.
After all evaluation survey data have been collected, the re-
search assistant (RA) will be unblinded to randomization
status. The RA will then administer a few qualitative ques-
tions to a random sample of intervention arm subjects to
get a Veteran-perspective of the quality of care received in
the intervention.
Cost assessment
Using data collected from the Activity logs and itemized
start-up costs, we will estimate separately both fixed and
variable start-up and implementation costs of the inter-
vention. Total costs for the intervention implementation
will be calculated, broken down as technical assistance
costs borne by the research team and implementation
costs attributable to clinical staff.
Health services utilization
We will aggregate and compare health services
utilization costs between the two study arms. The aver-
age cost per patient will be generated based on the admin-
istrative data and augmented by selected self-reported
healthcare use from the telephone survey. We will calcu-
late the costs associated with health services utilization in
the 12 months preceding intervention and during the
18 months of the intervention. Utilization will include
physician and emergency room visits, hospital admissions,
nursing home admissions, home care services, and
pharmacy data. We will determine the units of each ser-
vice utilized per patient and apply standard unit costs
from data costs of VA patient care encounters from the
VA Health Economics Resource Center (HERC) [35]. The
total cost of each participant will be examined between
intervention and usual care using a two-sample t test and
multivariate regression. Because costs may be skewed, we
will also repeat analyses after transforming the dependent
variable using square root and logarithmic functions.
Because of potential imbalances associated with the high
costs of end-of-life care, we will conduct a sensitivity ana-
lysis excluding participants who died during the study
period.
If the costs for the intervention arm are significantly
higher than usual care and significant improvements to
patient outcomes are observed, then we may perform a
formal cost-effectiveness analysis using the primary and
secondary outcomes. In addition, we also have the op-
tion of generating quality-adjusted life years (QALYs)
based on the Health Utilities Index collected during the
telephone interviews.
Limitations
There is a lack of generalizability inherent in nearly all
randomized controlled trials. However, we have few re-
strictions in inclusion and exclusion criteria, to maximize
the applicability of findings to most Veterans with PD,
and we are tracking and have some characteristics of those
who decline participation.
A challenge may be the complexity of the CHAPS
Program itself and the numerous clinical problems
that the NCMs, the Veterans, and VA clinicians may
need to address in any one patient. However, the
CHAPS Program, starting with a thorough structured
initial assessment, is designed to proactively identify
challenges in order to optimize PD management such
as access barriers and the non-motor features of
Parkinson’s disease. Identification of these challenges
early may decrease preventable complications like medica-
tion mismanagement and falls. This leads to simplified
clinical care with possibly fewer complications requiring
downstream care.
Protocol modifications
Some modifications have been made to the protocol
during the initial months of the study. Early in the im-
plementation phase, we interrupted the study to refine
the intervention in response to CHAPS nurse care man-
agers’ feedback.We sought out possible options to better
organize the CHAPS assessment and care delivery com-
ponents. We identified a practical, patient-centered cog-
nitive schema, the Siebens Domain Management Model
(SDMM) as a published framework, in clinical use, to as-
sist in the care of individuals with chronic conditions
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[36–39]. The model, which evolved from earlier work in
stroke rehabilitation [40], includes four domains, each
with a few subdomains:
I. Medical/Surgical Issues including aspects of disease
prevention and organ system function;
II. Mental Status/Emotions/Coping including cognitive
function and patient preferences;
III. Physical Function for the full range of patients’
function from basic to intermediate to advanced
activities of daily living; and
IV. Living Environment including core elements of the
patient’s environment (©Hilary C Siebens MD 2005).
Through consultation with, and permission from,
the SDMM creator, we reorganized the CHAPS as-
sessment to follow the SDMM’s 4 domains, as already
shown in Table 2. The priority problems, triggered by
the assessment, and their corresponding care plans
also were ordered using the SDMM (Table 2). Next,
the SDMM was integrated into the CHAPS communi-
cation templates for Veterans (My Action Plan) and
in all the electronic CHAPS medical record MS Word
templates for NCM documentation for communicat-
ing with physicians and other clinicians. We agreed
that this structure would increase the NCM’s ability
to identify key health-related issues and make it easy
for other clinicians to find relevant CHAPS Program
information in the electronic medical record.
In addition, we adopted the 3-ringed binder, the
Siebens Health Care Notebook (SHC Notebook) as a
better patient self-management tool than a more
general binder [41–43]. Four sections, one for each
domain, facilitate disaggregating multiple problems
into more manageable categories. Also, simplifying
the organization of material into four sections can
potentially increase Veterans’ self-management ability.
Having a piece of information in one section or solv-
ing a problem in one area may help solve problems
in others. The SHC Notebook is customized for PD
by adding one standard PD-related education sheet in
each domain section for all patients. NCMs add
custom education sheets to individualize these Note-
books depending on patients’ priorities and identified
priority problems. Individualized customization also
included re-designed “My Action Plans” that incor-
porated the 4 SDMM-domains.
We will administer 5–10 min surveys to the interven-
tion arm NCMs and clinician champions at each partici-
pating VA site about the usability of the Siebens Domain
Management Model and the Siebens Health Care
Notebook in the intervention. To analyze these data, we
will explore common themes guided by the implementa-
tion evaluation concepts.
The study has experienced an unexpected decrease in
NCM availability due to hiring challenges with bringing
identified new nurses on as employees in the VA. Thus,
analysis needed to be revised to account for the gap in re-
ceipt of the intervention among some of the initial trial
cohort. Because of this, a 24-month survey was added to
the study for the first 204 enrollees. The remaining sub-
jects (see below for change in sample size) will be followed
for the pre-defined 18 months. In order to combine both
of these “cohorts” into a complete analysis, a variable will
be incorporated into the regression models to reflect the
period of time the subject was off the intervention. Re-
evaluation of our power analysis indicates a total analytic
sample of 266 enrollees (133 in each arm), is required for
a medium effect size of about 0.4 SD (Cohen’s termin-
ology) and 90 % power (Table 4). We aim to enroll 320
subjects, estimating attrition around 17 %, to achieve this
analytic sample.
Discussion
The CHAPS Program is a promising approach to
proactively address both motor and non-motor health
problems in Veterans with Parkinson’s disease. Results
from this trial will provide insights on proactive care co-
ordination provided through NCMs for Veterans with
Parkinson’s disease. The work has evolved from earlier
health services research that identified gaps in care. Basing
the program design on the Chronic Care Model facilitated
designing a multi-faceted intervention that we anticipate
addresses the patients’ clinical complexities effectively. We
are helped in this goal by the availability of PD quality
indicators and collaboration with experts within and out-
side the Veterans Affairs to help prioritize these quality
indicators.
We also believe that using the SDMM and SHC
Notebook will address the care coordination challenge
of organizing multiple health-related problems patients
may have. This standardized framework and Notebook
will facilitate teaching nurses, and others, about
Veterans’ care. Second, they may strengthen interdiscip-
linary communication among patient, family, and health
care providers.
The CHAPS Program’s structure, including nurse care
managers, standardized assessments and care manage-
ment protocols may be scalable. Therefore, we will share
findings on implementation barriers before the study
ends. These may be applicable and relevant to adminis-
trators, clinicians, and health services researchers study-
ing other chronic diseases. If the CHAPS Program is
demonstrated efficacious, it is poised for dissemination
within VA National Parkinson’s Disease Research,
Education, and Clinical Center Consortium. Findings
will be relevant to all audiences concerned with improv-
ing the quality of life of patients with chronic conditions.
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